Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction.
作者信息
Fares Wassim H, Kaminski Naftali
机构信息
1 Section of Pulmonary, Critical Care and Sleep Medicine Department of Medicine Yale University School of Medicine New Haven, Connecticut.
出版信息
Am J Respir Cell Mol Biol. 2017 Apr;56(4):421-422. doi: 10.1165/rcmb.2017-0035ED.
Abstract
摘要
相似文献
1
Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction.最后，射血分数保留的心力衰竭相关肺动脉高压的研究进展。
Am J Respir Cell Mol Biol. 2017 Apr;56(4):421-422. doi: 10.1165/rcmb.2017-0035ED.
2
Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives.射血分数保留的心力衰竭中的肺动脉高压：患病率、病理生理学及临床展望
Circ Heart Fail. 2014 Mar 1;7(2):367-77. doi: 10.1161/CIRCHEARTFAILURE.113.000823.
3
Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction.射血分数降低的晚期心力衰竭合并毛细血管前和毛细血管后肺动脉高压的管理。
Respir Med. 2017 Oct;131:94-100. doi: 10.1016/j.rmed.2017.08.006. Epub 2017 Aug 9.
4
[Prognostic importance of pulmonary hypertension in heart failure with preserved ejection fraction].射血分数保留的心力衰竭中肺动脉高压的预后重要性
Rev Clin Esp. 2010 Nov;210(10):489-96. doi: 10.1016/j.rce.2010.04.019. Epub 2010 Sep 19.
5
Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research.射血分数保留的心力衰竭中的肺动脉高压：呼吁进行恰当的表型分析并开展进一步研究。
Eur Heart J. 2017 Oct 7;38(38):2869-2873. doi: 10.1093/eurheartj/ehw597.
6
Development of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者肺动脉高压的发生
Prog Cardiovasc Dis. 2016 Jul-Aug;59(1):52-8. doi: 10.1016/j.pcad.2016.06.002. Epub 2016 Jun 24.
7
The role of the pulmonary vasculature in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中肺血管系统的作用。
J Am Coll Cardiol. 2009 Mar 31;53(13):1127-9. doi: 10.1016/j.jacc.2009.01.006.
8
Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study.雷诺嗪治疗射血分数保留的心力衰竭相关性肺动脉高压：一项初步研究。
J Heart Lung Transplant. 2016 Nov;35(11):1370-1373. doi: 10.1016/j.healun.2016.07.015. Epub 2016 Jul 27.
9
Pulmonary hypertension in heart failure with preserved ejection fraction any pathophysiological role of mitral regurgitation.射血分数保留的心力衰竭中的肺动脉高压：二尖瓣反流的任何病理生理作用。
J Am Coll Cardiol. 2009 Sep 22;54(13):1191-2; author reply 1192. doi: 10.1016/j.jacc.2009.04.088.
10
Heart failure with preserved ejection fraction.射血分数保留的心力衰竭
N Engl J Med. 2006 Oct 26;355(17):1828; author reply 1830-1. doi: 10.1056/NEJMc062229.
本文引用的文献
1
Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction.代谢综合征、肺动脉高压和射血分数保留的心力衰竭小鼠模型的建立。
Am J Respir Cell Mol Biol. 2017 Apr;56(4):497-505. doi: 10.1165/rcmb.2016-0177OC.
2
Mouse Genome-Wide Association Study of Preclinical Group II Pulmonary Hypertension Identifies Epidermal Growth Factor Receptor.临床前II型肺动脉高压的小鼠全基因组关联研究确定了表皮生长因子受体。
Am J Respir Cell Mol Biol. 2017 Apr;56(4):488-496. doi: 10.1165/rcmb.2016-0176OC.
3
Gender Disparities Across the Spectrum of Advanced Cardiac Therapies: Real or Imagined?先进心脏治疗全领域的性别差异：是真实存在还是想象出来的？
Curr Cardiol Rep. 2016 Nov;18(11):108. doi: 10.1007/s11886-016-0783-0.
4
Bias in the reporting of sex and age in biomedical research on mouse models.小鼠模型生物医学研究中性别和年龄报告的偏差。
Elife. 2016 Mar 3;5:e13615. doi: 10.7554/eLife.13615.
5
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.《2016年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
6
Opinion: Sex inclusion in basic research drives discovery.观点：基础研究纳入性别因素推动发现。
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5257-8. doi: 10.1073/pnas.1502843112. Epub 2015 Apr 20.
7
Policy: NIH to balance sex in cell and animal studies.政策：NIH 将在细胞和动物研究中平衡性别。
Nature. 2014 May 15;509(7500):282-3. doi: 10.1038/509282a.
8
Sex differences in the pulmonary circulation: implications for pulmonary hypertension.肺循环中的性别差异：对肺动脉高压的影响。
Am J Physiol Heart Circ Physiol. 2014 May;306(9):H1253-64. doi: 10.1152/ajpheart.00857.2013. Epub 2014 Mar 7.
9
MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach.miRNA-21 通过整合致病信号来控制肺动脉高压：网络生物信息学方法的研究结果。
Circulation. 2012 Mar 27;125(12):1520-32. doi: 10.1161/CIRCULATIONAHA.111.060269. Epub 2012 Feb 27.
10
Role of epidermal growth factor inhibition in experimental pulmonary hypertension.表皮生长因子抑制在实验性肺动脉高压中的作用。
Am J Respir Crit Care Med. 2010 Jan 15;181(2):158-67. doi: 10.1164/rccm.200811-1682OC. Epub 2009 Oct 22.
Zotero 插件